Literature DB >> 8375338

Multiple extracellular signals are required for long-term oligodendrocyte survival.

B A Barres1, R Schmid, M Sendnter, M C Raff.   

Abstract

We showed previously that oligodendrocytes and their precursors require continuous signalling by protein trophic factors to avoid programmed cell death in culture. Here we show that three classes of such trophic factors promote oligodendrocyte survival in vitro: (1) insulin and insulin-like growth factors (IGFs), (2) neurotrophins, particularly neurotrophin-3 (NT-3), and (3) ciliary-neurotrophic factor (CNTF), leukemia inhibitory factor (LIF) and interleukin 6 (IL-6). A single factor, or combinations of factors within the same class, promote only short-term survival of oligodendrocytes and their precursors, while combinations of factors from different classes promote survival additively. Long-term survival of oligodendrocytes in vitro requires at least one factor from each class, suggesting that multiple signals may be required for long-term oligodendrocyte survival in vivo. We also show that CNTF promotes oligodendrocyte survival in vivo, that platelet-derived growth factor (PDGF) can promote the survival of oligodendrocyte precursors in vitro by acting on a novel, very high affinity PDGF receptor, and that, in addition to its effect on survival, NT-3 is a potent mitogen for oligodendrocyte precursor cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375338     DOI: 10.1242/dev.118.1.283

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  185 in total

Review 1.  Regulation of oligodendrocyte development.

Authors:  D M Orentas; R H Miller
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

2.  Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB.

Authors:  C Meier; E Parmantier; A Brennan; R Mirsky; K R Jessen
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

3.  Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell.

Authors:  J Smith; E Ladi; M Mayer-Proschel; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Sparks and puffs in oligodendrocyte progenitors: cross talk between ryanodine receptors and inositol trisphosphate receptors.

Authors:  L L Haak; L S Song; T F Molinski; I N Pessah; H Cheng; J T Russell
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  Induction of oligodendrocyte apoptosis by C2-ceramide.

Authors:  J N Larocca; M Farooq; W T Norton
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

6.  NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes.

Authors:  Jonah R Chan; Trent A Watkins; José M Cosgaya; ChunZhao Zhang; Lian Chen; Louis F Reichardt; Eric M Shooter; Ben A Barres
Journal:  Neuron       Date:  2004-07-22       Impact factor: 17.173

7.  Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase.

Authors:  Ying Zhu; Jinsil Park; Xuemei Hu; Kang Zheng; Hong Li; Qilin Cao; Gen-Sheng Feng; Mengsheng Qiu
Journal:  Glia       Date:  2010-09       Impact factor: 7.452

8.  Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.

Authors:  Ajaib S Paintlia; Sarumathi Mohan; Inderjit Singh
Journal:  J Clin Cell Immunol       Date:  2013-06-30

9.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease.

Authors:  Ming Tong; Raiane Leão; Gina V Vimbela; Emine B Yalcin; Jared Kay; Alexander Krotow; Suzanne M de la Monte
Journal:  Mol Cell Neurosci       Date:  2017-04-21       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.